Prevention of graft-versus-host disease in DLA-haplotype mismatched dogs and hemopoietic engraftment of CD6-depleted marrow with and without cG-CSF treatment after transplantation.

No abstract is available for this paper.

• Publication year

  1994

• Venue

  Tissue Antigens

• Publication date

  1994-03-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1111/J.1399-0039.1994.TB02318.XPMID 7522357
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Identification of four MLC-specificities in the dog.

  2008cited by this paper
• Spontaneous tumor cell cytotoxicity mediated by peripheral blood mononuclear leukocytes of the dog.

  1993cited by this paper
• T-cell-depleted allogeneic bone marrow transplantation in adults with acute nonlymphocytic leukemia in first remission.

  1992cited by this paper
• Prevention of graft-versus-host disease by selective depletion of CD6-positive T lymphocytes from donor bone marrow.

  1992cited by this paper
• Bone marrow transplantation from related donors other than HLA-identical siblings: effect of T cell depletion.

  1991cited by this paper
• The lymphocyte glycoprotein CD6 contains a repeated domain structure characteristic of a new family of cell surface and secreted proteins

  1991cited by this paper
• Graft-versus-leukaemia following allogeneic bone marrow transplantation: emergence of cytotoxic T lymphocytes reacting to host leukaemia cells.

  1991cited by this paper
• Donor Leukocyte Transfusions for Treatment of Recurrent Chronic Myelogenous Leukemia in Marrow Transplant Patients

  1990cited by this paper
• Preservation of lymphokine-activated killer activity following T cell depletion of human bone marrow.

  1990cited by this paper
• Antigen density on target cells determines the immunosuppressive potential of rat IgG2b monoclonal antibodies

  1990cited by this paper
• Reconstitution of T-cell function after CD6-depleted allogeneic bone marrow transplantation.

  1990cited by this paper
• Immunomagnetic depletion of CD6+ cells from bone marrow and peripheral blood.

  1990cited by this paper
• Natural history of mixed chimerism after bone marrow transplantation with CD6-depleted allogeneic marrow: a stable equilibrium.

  1990cited by this paper
• Donor leukocyte transfusions for treatment of recurrent chronic myelogenous leukemia in marrow transplant patients.

  1990cited by this paper
• Mechanism of graft failure in HLA-matched and HLA-mismatched bone marrow transplant recipients.

  1989cited by this paper
• Graft failure after T-cell-depleted human leukocyte antigen identical marrow transplants for leukemia: I. Analysis of risk factors and results of secondary transplants

  1989cited by this paper
• Graft failure after T-cell-depleted human leukocyte antigen identical marrow transplants for leukemia: I. Analysis of risk factors and results of secondary transplants.

  1989cited by this paper
• Bone marrow transplantation for chronic myelogenous leukemia in chronic phase. Increased risk for relapse associated with T-cell depletion.

  1988cited by this paper
• Graft failure in patients receiving T cell-depleted HLA-identical allogeneic marrow transplants.

  1988cited by this paper
• Bone marrow transplantation for chronic myelogenous leukemia in chronic phase. Increased risk for relapse associated with T-cell depletion.

  1988cited by this paper
• T CELL DEPLETION WITH CAMPATH‐1 IN ALLOGENEIC BONE MARROW TRANSPLANTATION

  1988cited by this paper
• In vivo immunosuppression by pan-T cell antibodies relates to their isotype and to their C1q uptake.

  1987cited by this paper
• Risk factors for acute graft‐versus‐host disease

  1987cited by this paper
• Antilymphocytic antibodies and marrow transplantation. VIII. Recipient conditioning with Clq-affine monoclonal anti-pan T antibodies prevents GVHD in homozygous fully mismatched mice.

  1986cited by this paper
• Bone marrow transplantation for patients with chronic myeloid leukemia.

  1986cited by this paper
• Graft-versus-host disease following transplantation of 'one log' versus 'two log' T-lymphocyte-depleted bone marrow from HLA-identical donors.

  1986cited by this paper
• Demonstration of clonable alloreactive host T cells in a primate model for bone marrow transplantation.

  1986cited by this paper
• Effects of in vitro depletion of T cells in HLA-identical allogeneic marrow grafts.

  1985cited by this paper
• Antilymphocytic antibodies and marrow transplantation. VII. Two of nine monoclonal anti-Thy-1 antibodies used for pretreatment of donor marrow suppressed graft-versus-host reactions without added complement.

  1985cited by this paper
• QUANTITATION OF T LYMPHOCYTES IN HUMAN BONE MARROW BY A LIMITING DILUTION ASSAY

  1985cited by this paper
• Effects of in vitro depletion of T cells in HLA-identical allogeneic marrow grafts

  1985cited by this paper
• Removal of T cells from bone marrow for transplantation: a monoclonal antilymphocyte antibody that fixes human complement.

  1983cited by this paper
• Myelopoiesis of human bone marrow cells in a micro-agar culture system: comparison of two sources of colony stimulating activity (CSA).

  1983cited by this paper
• Limiting dilution assays for the determination of immunocompetent cell frequencies. I. Data analysis.

  1981cited by this paper
• Bone marrow transplantation in DLA-haploidentical canine littermates: fractionated total body irradiation (FTBI) and in vitro treatment of the marrow graft with anti-T-cell globulin (ATCG).

  1980cited by this paper
• ANTILYMPHOCYTIC ANTIBODIES AND MARROW RANSPLANTATION: VI. GRAFT‐VERSUS-HOST TOLERANCE IN DLA‐INCOMPATIBLE DOGS AFTER IN VITRO TREATMENT OF BONE MARROW WITH ABSORBED ANTITHYMOCYTE GLOBULIN

  1979cited by this paper
• GVHD suppression by incubation of bone marrow grafts with anti-T-cell globulin: effect in the canine model and application to clinical bone marrow transplantation.

  1979cited by this paper

• The FLAMSA concept—past and future

  2020cites this paper
• Transplantation of CD6-depleted peripheral blood stem cells after DLA-haploidentical bone marrow transplantation contributes to engraftment and tolerance in a preclinical model of stem cell transplantation.

  2011cites this paper
• Tolerance in DLA-haploidentical canine littermates following CD6-depleted marrow transplantation and donor lymphocyte transfusion.

  2009cites this paper
• Charakterisierung von Antikörpern und ihrer immunsuppressiven Wirkung im präklinischen Transplantationsmodell des Hundes

  2007cites this paper
• Haploidentical Stem Cell Transplantation

  2004cites this paper
• Tolerance and chimerism1

  2003cites this paper
• Determination of donor-type chimerism using a semi-quantitative PCR-based method in a canine model for bone marrow transplantation.

  2002cites this paper
• Allogeneic hematopoietic stem cell transplantation in recipients of cellular or solid organ allografts.

  1999cites this paper
• Detection, cDNA cloning and sequencing of canine interleukin 12.

  1998cites this paper
• Adoptive immunotherapy in canine chimeras.

  1997cites this paper
• Hematopoietic growth factors: frontiers for cure.

  1995cites this paper
• NK activity of canine blood and marrow cells.

  1994cites this paper
• The immunology of companion animals: reagents and therapeutic strategies with potential veterinary and human clinical applications.

  1994cites this paper
• Monoclonal antibodies that define canine homologues of human CD antigens: summary of the First International Canine Leukocyte Antigen Workshop (CLAW).

  1994cites this paper